what is RU for exactly? maintenance or can it cause some regrow too?
    Finasteride/Dutasteride 4/18/2024

    From the encyclopedia
    RU58841 β†’

    a potent but unapproved and potentially problematic topical anti-androgen

    Finasteride β†’

    Frontline, gold standard treatment for combatting androgenic alopecia

    At a glance
    In this question or advice post, the primary subjects mentioned are
    πŸ’§ RU58841 (topical) 2 weeks
    πŸ’Š Finasteride (oral)
    the tone is 😐 neutral.

    Other terms

    RU58841 is being discussed for its effects on hair loss. The user has started using RU58841 with finasteride and is curious about its potential for hair maintenance or regrowth.
    View this post in the Community β†’

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results
      Alopecia: The Search for Novel Agents Continues

      research Alopecia - the search for novel agents continues

      11 citations , August 1997 in “Expert Opinion on Therapeutic Patents”
      This review discusses nearly 70 patent applications for the treatment of androgenetic alopecia and other hair conditions, highlighting the mechanisms of action explored but reports no clinical results.
      Male Androgenetic Alopecia

      research Male androgenetic alopecia

      54 citations , July 2002 in “Clinical and Experimental Dermatology”
      This article provides a critical overview of recent discoveries in the genetics and molecular processes involved in androgenetic alopecia, focusing on its polygenic basis and DHT dependency, but reports no new clinical results.
      5Ξ±-Reduced Glucocorticoids: A Story of Natural Selection

      research 5Ξ±-Reduced glucocorticoids: a story of natural selection

      46 citations , September 2011 in “Journal of Endocrinology”
      This study suggests that 5Ξ±-reduced glucocorticoids may have anti-inflammatory potential and could serve as biomarkers for liver inflammation in metabolic disease, with implications for drug development.
      Experimental and Early Investigational Drugs for Androgenetic Alopecia

      research Experimental and early investigational drugs for androgenetic alopecia

      11 citations , July 2017 in “Expert Opinion on Investigational Drugs”
      This review discusses current and emerging therapeutic strategies for androgenetic alopecia, noting limited evidence but suggesting areas such as prostaglandin analogs, PRP, and progenitor cell therapies as promising future directions.